EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells

Danielle Sandra Nkandeu, Anna Margaretha Joubert, June Cheptoo Serem, Priyesh Bipath, Yvette Nkondo Hlophe

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.4065 ↗

At a glance

Journal article in Cell Biochemistry and Function, 2024. Written by Danielle Sandra Nkandeu and 4 co-authors. Institution: Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Major MEDLINE topics: Hemangioendothelioma, Kynurenine. Cited 2 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: The National Research Foundation (NRF), The University Capacity Development Programme (UCDP), National Research Foundation.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cancer is the second leading cause of mortality worldwide. The development of anticancer therapy plays a crucial role in mitigating tumour progression and metastasis. Epithelioid hemangioendothelioma is a very rare cancer, however, with a high systemic involvement. Kynurenine metabolites which include l ‐kynurenine, 3‐hydroxykynurenine, 3‐hydroxyanthranilic acid and quinolinic acid have been shown to inhibit T‐cell proliferation resulting in a decrease in cell growth of natural killer cells and T cells. Furthermore, metabolites such as l ‐kynurenine have been shown to inhibit proliferation of melanoma cells in vitro. Considering these metabolite properties, the present study aimed to explore the in vitro effects of l ‐kynurenine, quinolinic acid and kynurenic acid on endothelioma sEnd‐2 cells and on endothelial (EA. hy926 cells) (control cell line). The in vitro effect at 24, 48, and 72 h exposure to a range of 1−4 mM of the respective kynurenine metabolites on the two cell lines in terms of cell morphology, cell cycle progression and induction of apoptosis was assessed. The half inhibitory concentration (IC 50 ), as determined using nonlinear regression, for l ‐kynurenine, quinolinic acid and kynurenic acid was 9.17, 15.56, and 535.40 mM, respectively. Optical transmitted light differential interference contrast and hematoxylin and eosin staining revealed cells blocked in metaphase, formation of apoptotic bodies and compromised cell density in l ‐kynurenine‐treated cells. A statistically significant increase in the number of cells present in the sub‐G 1 phase was observed in l ‐kynurenine‐treated sample. To our knowledge, this was the first in vitro study conducted to investigate the mechanism of action of kynurenine metabolites on endothelioma sEnd‐2 cells. It can be concluded that l ‐kynurenine exerts an antiproliferative effect on the endothelioma sEnd‐2 cell line by decreasing cell growth and proliferation as well as a metaphase block. These hallmarks suggest cell death via apoptosis. Further research will be conducted on l ‐kynurenine to assess the effect on cell adhesion in vitro and in vivo as cell‐cell adhesion has been shown to increase metastasis to distant organs therefore, the inhibition of adhesion may lead to a decrease in metastasis.

Subjects

MeSH terms (MEDLINE)

HemangioendotheliomaKynurenineAnimalsMiceCells, CulturedMice, Inbred C57BLCell CycleQuinolinic AcidKynurenic AcidGentian VioletCell Proliferation

Author keywords

apoptosisendotheliomakynurenic acidl‐kynureninequinolinic acid

Substances

KynurenineQuinolinic AcidKynurenic AcidGentian Violet

Authors and institutions

  • Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Department of Anatomy, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Funding

  • The National Research Foundation (NRF)
  • The University Capacity Development Programme (UCDP)
  • National Research Foundation

Cite

APA

Nkandeu, D. S., Joubert, A. M., Serem, J. C., Bipath, P., & Hlophe, Y. N. (2024). An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.4065

Vancouver

Nkandeu DS, Joubert AM, Serem JC, Bipath P, Hlophe YN. An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.4065

BibTeX
@article{Nkandeu2024,
  author = {Nkandeu, Danielle Sandra and Joubert, Anna Margaretha and Serem, June Cheptoo and Bipath, Priyesh and Hlophe, Yvette Nkondo},
  title = {An exploratory study on the effect of kynurenine metabolites on sEnd‐2 endothelioma cells},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.4065}
}
Start for free →